Criteria for Metabolic Response to Therapy Seen on PET Scan

Purpose: To determine the metabolic response to therapy seen in a non-small-cell lung cancer (NSCLC) on [18F]FDG PET scan.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient who has been treated for a non-small-cell lung cancer?

Yes

Has sufficient time passed for therapy-related inflammation in the tumor to subside?

Yes

Peak FDG uptake in the tumor before treatment

SUV

Current FDG uptake in the tumor

SUV

Mean SUV of the aortic arch

SUV

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Ratio of the FDG uptake after treatment to FDG uptake before treatment

The patient is showing

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Pharmacokinetic Test Dose to Detect Risk for Excessive Toxicity Prior to 5-Fluorouracil Therapy
Criteria For Diagnosis
- World Health Organization (WHO) Criteria for Tumor Response to Therapy
Severity, Prognosis, Stage
- World Health Organization (WHO) Criteria for Tumor Response to Therapy

Therapy

Options
- World Health Organization (WHO) Criteria for Tumor Response to Therapy
Selection
- World Health Organization (WHO) Criteria for Tumor Response to Therapy
- Pharmacokinetic Test Dose to Detect Risk for Excessive Toxicity Prior to 5-Fluorouracil Therapy
Dosage Adjustments
- Irinotecan Dosage Adjustment for Colon Cancer and Hepatic Dysfunction

Monitoring

Response To Therapy
- World Health Organization (WHO) Criteria for Tumor Response to Therapy
- UICC Criteria for Tumor Response Following Therapy
Disease Progression
- World Health Organization (WHO) Criteria for Tumor Response to Therapy

Specialty

Hematology Oncology
Surgery, general

Objective

response to therapy

ICD-10

C39.9 - Malignant neoplasm, ill-defined sites within the respiratory system

Info

Purpose: To determine the metabolic response to therapy seen in a non-small-cell lung cancer (NSCLC) on [18F]FDG PET scan.

Specialty: Hematology Oncology, Surgery, general

Objective: response to therapy

ICD-10: C39.9,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path